Volume 120, Issue 2, Pages (January 2005)

Slides:



Advertisements
Similar presentations
Smita Srivastava, Patricia S. Grace, Joel D. Ernst  Cell Host & Microbe 
Advertisements

Cantharidin Inhibits the Growth of Triple-Negative Breast Cancer Cells by Suppressing Autophagy and Inducing Apoptosis in Vitro and in.
The Autophagy Inhibitor Chloroquine Overcomes the Innate Resistance of Wild-Type EGFR Non-Small-Cell Lung Cancer Cells to Erlotinib  Yiyu Zou, PhD, Yi-He.
Identification of the Major Intestinal Fatty Acid Transport Protein
Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor–κB and IκBα kinase in human multiple myeloma cells, leading to.
The TCL1 oncoprotein inhibits activation-induced cell death by impairing PKCθ and ERK pathways by Gilles Despouy, Marjorie Joiner, Emilie Le Toriellec,
Jaya Sahni, Andrew M. Scharenberg  Cell Metabolism 
Xeroderma Pigmentosum Group A Promotes Autophagy to Facilitate Cisplatin Resistance in Melanoma Cells through the Activation of PARP1  Rui Ge, Lin Liu,
Volume 18, Issue 5, Pages (May 2010)
Levels of Polyadenylation Factor CstF-64 Control IgM Heavy Chain mRNA Accumulation and Other Events Associated with B Cell Differentiation  Yoshio Takagaki,
Effects of Betulinic Acid Alone and in Combination with Irradiation in Human Melanoma Cells  Edgar Selzer, Emilio Pimentel, Volker Wacheck, Werner Schlegel,
Methods in Mammalian Autophagy Research
NF1 silencing confers resistance of PC9 lung adenocarcinoma cells to erlotinib (erl). NF1 silencing confers resistance of PC9 lung adenocarcinoma cells.
Cathepsin-B-dependent apoptosis triggered by antithymocyte globulins: a novel mechanism of T-cell depletion by Marie-Cécile Michallet, Frederic Saltel,
I LC3 II a-Tubulin Figure S1 Ctrl Myoblasts 0h shMLP Myoblasts 0 h
Volume 11, Issue 6, Pages (June 2012)
Volume 120, Issue 6, Pages (March 2005)
Volume 44, Issue 3, Pages (November 2011)
The Autophagy Inhibitor Chloroquine Overcomes the Innate Resistance of Wild-Type EGFR Non-Small-Cell Lung Cancer Cells to Erlotinib  Yiyu Zou, PhD, Yi-He.
Volume 110, Issue 11, Pages (June 2016)
Volume 18, Issue 3, Pages (April 2005)
Volume 45, Issue 5, Pages (March 2012)
Volume 27, Issue 1, Pages (July 2007)
Inhibition of KLF4 by Statins Reverses Adriamycin-Induced Metastasis and Cancer Stemness in Osteosarcoma Cells  Yangling Li, Miao Xian, Bo Yang, Meidan.
IL-15Rα Recycles and Presents IL-15 In trans to Neighboring Cells
Volume 13, Issue 5, Pages (May 2008)
Volume 41, Issue 2, Pages (January 2011)
Andrew J Henderson, Ruth I Connor, Kathryn L Calame  Immunity 
Distinct Autophagosomal-Lysosomal Fusion Mechanism Revealed by Thapsigargin- Induced Autophagy Arrest  Ian G. Ganley, Pui-Mun Wong, Noor Gammoh, Xuejun.
Volume 50, Issue 2, Pages (April 2006)
Thymidylate synthase as an oncogene
Modeling the Therapeutic Efficacy of p53 Restoration in Tumors
Calmodulin-Like Protein Upregulates Myosin-10 in Human Keratinocytes and Is Regulated during Epidermal Wound Healing In Vivo  Richard D. Bennett, Amy.
Volume 91, Issue 5, Pages (November 1997)
Phospholipid Scramblase 1 Mediates Type I Interferon-Induced Protection against Staphylococcal α-Toxin  Miroslaw Lizak, Timur O. Yarovinsky  Cell Host.
Jungmook Lyu, Vicky Yamamoto, Wange Lu  Developmental Cell 
Volume 22, Issue 2, Pages (January 2012)
Volume 15, Issue 6, Pages (June 2012)
Volume 6, Issue 3, Pages (September 2000)
Volume 50, Issue 2, Pages (April 2006)
Death Receptor-Independent Apoptosis in Malignant Melanoma Induced by the Small- Molecule Immune Response Modifier Imiquimod  Michael P. Schön, B. Gregor.
Antigen-Loading Compartments for Major Histocompatibility Complex Class II Molecules Continuously Receive Input from Autophagosomes  Dorothee Schmid,
Oncogenic Ras-Induced Expression of Noxa and Beclin-1 Promotes Autophagic Cell Death and Limits Clonogenic Survival  Mohamed Elgendy, Clare Sheridan,
Volume 18, Issue 8, Pages (August 2011)
Volume 56, Issue 5, Pages (December 2014)
Volume 20, Issue 12, Pages (September 2017)
Volume 6, Issue 1, Pages (January 1997)
Fateh Ouaaz, Joseph Arron, Ye Zheng, Yongwon Choi, Amer A Beg  Immunity 
Volume 50, Issue 2, Pages (April 2013)
Resistance of Human Melanoma Cells Against the Death Ligand TRAIL Is Reversed by Ultraviolet-B Radiation via Downregulation of FLIP  Elke Zeise, Michael.
MTORC1 Negatively Regulates the Replication of Classical Swine Fever Virus Through Autophagy and IRES-Dependent Translation  Qinghua Luo, Li Zhang, Feng.
PPARδ Is a Type 1 IFN Target Gene and Inhibits Apoptosis in T Cells
Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance  Valeria R. Fantin, Julie St-Pierre,
EVA1A/TMEM166 Regulates Embryonic Neurogenesis by Autophagy
Interferon-γ-Mediated Growth Regulation of Melanoma Cells: Involvement of STAT1- Dependent and STAT1-Independent Signals  Anja Bosserhoff  Journal of Investigative.
Volume 129, Issue 5, Pages (June 2007)
Volume 129, Issue 2, Pages (April 2007)
Identification of Aneuploidy-Selective Antiproliferation Compounds
Volume 125, Issue 4, Pages (May 2006)
Targeted Cleavage of Signaling Proteins by Caspase 3 Inhibits T Cell Receptor Signaling in Anergic T Cells  Irene Puga, Anjana Rao, Fernando Macian  Immunity 
Negative Selection at the Pre-BCR Checkpoint Elicited by Human μ Heavy Chains with Unusual CDR3 Regions  Yoshiyuki Minegishi, Mary Ellen Conley  Immunity 
Volume 3, Issue 5, Pages (May 2001)
The CD28 Signaling Pathway Regulates Glucose Metabolism
Signaling via Mitogen-Activated Protein Kinase Kinase (MEK1) Is Required for Golgi Fragmentation during Mitosis  Usha Acharya, Arrate Mallabiabarrena,
Jerry E. Chipuk, Ulrich Maurer, Douglas R. Green, Martin Schuler 
Volume 39, Issue 1, Pages (July 2003)
by Xuefang Cao, Xingming Deng, and W. Stratford May
Identification of the Major Intestinal Fatty Acid Transport Protein
Volume 22, Issue 3, Pages (May 2006)
Pirh2 represses p73-dependent transactivation.
Presentation transcript:

Volume 120, Issue 2, Pages 237-248 (January 2005) Growth Factor Regulation of Autophagy and Cell Survival in the Absence of Apoptosis  Julian J. Lum, Daniel E. Bauer, Mei Kong, Marian H. Harris, Chi Li, Tullia Lindsten, Craig B. Thompson  Cell  Volume 120, Issue 2, Pages 237-248 (January 2005) DOI: 10.1016/j.cell.2004.11.046

Figure 1 Bax−/−Bak−/− Cells Undergo Atrophy and Maintain Prolonged Survival Following Withdrawal of Growth Factor (A) Two independent clones of Bax−/−Bak−/− IL-3-dependent cells (parental) stably transfected with either Bax, Bak, or empty vector (vec) were generated, and expression levels were assessed by Western blot. The IL-3-dependent Bax+/+Bak+/+ cell line FL5.12 is shown for comparison. (B) Kinetics of cell death in Bax- or Bak-reconstituted cells following IL-3 withdrawal. Viability was measured by propidium iodide exclusion. Data are averages of three experiments ± standard deviation (SD). (C) Cell viability of Bax−/−Bak−/− cells in the presence or absence of IL-3. Cells were washed and cultured in the presence (open squares) or absence (closed diamonds) of IL-3. At the indicated time points, cells were collected and viability was assessed. Cells grown in the presence of IL-3 were passaged every 2–3 days to restore a cell concentration of 7.5 × 105 cells/ml. The medium in IL-3-deprived cultures was replaced with an identical volume of fresh complete medium without IL-3 every 10 days. Data are averages of three independent experiments ± SD. (D) Cell numbers of cultures that were grown in the presence or absence of IL-3 and were cultured as in (C). Data are averages of three independent experiments ± SD. (E) Cell size of cultures that were grown in the presence or absence of IL-3 and were cultured as in (C). Data are averages of three independent experiments ± SD. Cell 2005 120, 237-248DOI: (10.1016/j.cell.2004.11.046)

Figure 2 Metabolic Effects of IL-3 Withdrawal on Bax−/−Bak−/− Cells (A) Glycolytic rate of cells grown in the absence of IL-3 as measured by the conversion of 5-3H-glucose to 3H2O at the indicated time points. The data presented at week 0 represent values of control cells growing in IL-3 throughout the time course of the experiment. Data are averages of three experiments ± SD. (B) Western blot analysis of GLUT1 expression in cells cultured in the absence of IL-3. The GLUT1 expression at week 0 is representative of GLUT1 expression of cells grown in IL-3. (C) Mitochondrial membrane potential as measured by TMRE staining in cells grown without IL-3 (solid histogram) at the indicated time point. Baseline TMRE was determined by using cells treated with the uncoupler CCCP (dotted histogram). The numbers in the top right corner indicate the average mean fluorescence intensity of three independent experiments. The week 0 time point indicates the mean fluorescence intensity of cells growing in IL-3 and is representative of the values obtained for such cells over the time course of the experiment. (D) ATP levels in cells grown without IL-3 and expressed as arbitrary units (AU). ATP levels for IL-3-grown cells did not decline significantly over the time course of the experiment (data not shown). Data are averages of three independent experiments ± SD. Cell 2005 120, 237-248DOI: (10.1016/j.cell.2004.11.046)

Figure 3 Growth Factor Withdrawal Induced Autophagosome Formation Is Required for Survival (A) Electron microscopy of cells grown in the absence of IL-3 for 48 hr (a–c) showing the presence of autophagosomes. Arrowheads depict representative autophagosomes quantitated in (d). Scale bar, 100 nm. (d) Quantitation of the number of autophagosomes per cross-sectioned cell cultured in the presence or absence of IL-3 for 48 hr. Error bar represents ±SD. Statistical significance determined by Student's t test. (B) Immunofluoresence with anti-LC3 antibody on cells grown in the presence (a) or absence (b) of IL-3 for 48 hr. Scale bar, 5 μm. (C) Immunoblot analysis of LC3-I processing into LC3-II in cells transfected with control or two independent shRNA constructs against ATG5 (hp-2 and hp-7) followed by culture in the presence or absence of IL-3 for 48 hr. Actin was used as a loading control. (D) Time course of cell viability following IL-3 withdrawal in cells with inactivation of ATG5. Data are averages of three experiments ± SD. Western blot analysis of ATG5 protein expression in cells transfected with vector control, hp-2, or hp-7 shRNA is shown as a representative experiment. Actin was used as loading control. (E) Time course of cell viability following IL-3 withdrawal in cells transfected with FITC tagged-siRNA for ATG7 (Yu et al., 2004) or a control siRNA. Cells which had incorporated the siRNA for ATG7 or control were purified by FACS sorting based on FITC-positive cells, and viability was assessed at the indicated time points. Data are averages of three experiments ± SD. Cell 2005 120, 237-248DOI: (10.1016/j.cell.2004.11.046)

Figure 4 Persistent Autophagy in Long-Term Growth Factor-Withdrawn Cells (A) Electron microscopy of cells grown in the presence (a) or absence (b) of IL-3 for 6 weeks. Scale bar, 8.5 μm. Magnification image of a cell grown in the presence (c) or absence (d) of IL-3 showing autophagosomes (arrows). Scale bar, 2.3 μm. Higher magnification of cells grown in the absence of IL-3 (e and f). Arrowheads depict autophagosomes in cells containing recognizable cellular material (e) or a late autophagosome fusing with a lysosome (f). Arrowheads depict representative autophagosomes quantitated in (B). Scale bar, 100 nm. (B) Quantitation of the number of autophagosomes per cross-sectioned cells cultured in the presence or absence of IL-3 for 6 weeks. Error bar represents ±SD. Statistical significance was determined by Student's t test. (C) Immunofluorescence of cells grown in the presence (a) or absence (b) of IL-3 for 6 weeks probed with anti-LC3 antibodies to detect autophagosomes. Scale bar, 12 μm. Cell 2005 120, 237-248DOI: (10.1016/j.cell.2004.11.046)

Figure 5 Cell Death Following Inhibition of Autophagy Is Reversed by Methylpyruvate (A) Viability of cells grown in the presence (top panel) or absence (bottom panel) of IL-3 for 6 weeks treated with 5 mM 3-MA (closed squares) or 10 μM CQ (open triangles). PBS was used as a vehicle control (closed diamonds). Data represent averages of three experiments ± SD. (B) Immunofluorescence staining of LC3 in cells grown in the presence (a) or absence (b) of IL-3 for 6 weeks. Cells grown in the presence or absence of IL-3 were treated for 18 hr with 5 mM 3-MA (c and d) or 10 μM CQ (e and f) followed by LC3 staining. PBS was used as a vehicle control. Scale bar, 10 μm. (C) DNA fragmentation assay was performed on Bax−/−Bak−/− cells grown in the presence or absence of IL-3 for 6 weeks and treated for 36 hr with 5 mM 3-MA, 10 μM CQ, or PBS as a vehicle control. IL-3-dependent Bax+/+Bak+/+ FL5.12 cells grown in the absence of IL-3 for 36 hr were used as a positive control for DNA laddering. (D) Viability of cells grown in the absence of IL-3 for 6 weeks after 18 hr of treatment with 5 mM 3-MA or 10 μM CQ in the presence or absence of 10 mM MP. (E) Viability of cells deprived of IL-3 for 6 weeks that were treated with 5 mM 3-MA or 10 μM CQ (open symbols) in the presence (closed squares and circles) or absence of 10 mM MP. Control cells were left untreated (closed diamonds). Data represent averages of three experiments ± SD. (F) ATP levels of cells grown in the absence of IL-3. Cells withdrawn from IL-3 for 6 weeks were treated with 10 mM MP or 5 mM 3-MA alone or together for 8 hr. ATP levels expressed as AU. Data represent average of three independent experiments ± SD. Cell 2005 120, 237-248DOI: (10.1016/j.cell.2004.11.046)

Figure 6 Cell Survival in Primary Bone Marrow Bax−/−Bak−/− Cells Is Controlled by Macroautophagy and Growth Factor Availability (A) Immunofluorescence staining with anti-LC3 antibodies of cells cultured in the presence or absence of IL-3 for 14 days. Scale bar, 5 μm. (B) Bax−/−Bak−/− bone marrow cells were cultured in the presence (open bars) or absence (solid bars) of IL-3 for 14 days. On day 14, cells were treated with 5 mM 3-MA or 10 μM CQ in the presence or absence of 10 mM MP. Cell viability was assessed by propidium iodide exclusion 36 hr later. Cell 2005 120, 237-248DOI: (10.1016/j.cell.2004.11.046)

Figure 7 IL-3 Restimulates Glycolysis and Growth/Proliferation in Growth Factor-Deprived Cells (A) Cell surface staining of IL-3 receptor α chain. Dotted histogram represents isotype control and solid histogram represents IL-3 receptor expression. Representative of three independent experiments. (B) Glycolytic rate of cells following readdition of IL-3. IL-3 was readded to cells that were cultured in the absence of IL-3 for 4 weeks and collected at the indicated time points for measurement of glycolytic rate. Solid line indicates average glycolytic rate of cells grown in the presence of IL-3 over the time course of the experiment. The hatched area represents ±1 SD. Representative of three independent experiments. (C and D) Cell size and cell number of cultures cultured without IL-3 for 2 (closed squares) or 6 (open triangles) weeks followed by readdition of IL-3. Data represent average of three experiments ± SD. (E) Cell size recovery following IL-3 readdition is dependent on the duration of deprivation. Histogram of mean cell size (fL) in cells restimulated with IL-3 for the indicated number of days following 2 (left panel) or 6 (right panel) weeks of growth factor withdrawal. Cell 2005 120, 237-248DOI: (10.1016/j.cell.2004.11.046)